Clinical Trial Update: A French Observational Study of Indocyanine Green for Patients With Breast Cancer Having a Sentinel Lymph Node Biopsy.

View source ↗

Summary

A completed observational clinical trial evaluating the use of indocyanine green for sentinel lymph node biopsy in breast cancer patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Indocyanine Green (Indocyanine Green)

Snippet

Sponsor: BTG International Inc. | Conditions: Breast Cancer | Status: COMPLETED